Rewalk Robotics Ltd (RWLK) was Initiated by Piper Jaffray to “Overweight” and the brokerage firm has set the Price Target at $10. Piper Jaffray advised their investors in a research report released on Jul 15, 2016.
On the company’s financial health, Rewalk Robotics Ltd reported $-0.48 EPS for the quarter, beating the analyst consensus estimate by $ 0.12 according to the earnings call on May 5, 2016. Analyst had a consensus of $-0.60. The company had revenue of $2.06 million for the quarter, compared to analysts expectations of $1.61 million. The company’s revenue was up 224.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.48 EPS.
Rewalk Robotics Ltd closed down -0.06 points or -0.86% at $6.93 with 53,978 shares getting traded on Wednesday. Post opening the session at $7.09, the shares hit an intraday low of $6.85 and an intraday high of $7.3999 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.
In a different news, on May 26, 2016, Jodi Gricci (VP Global Marktng & Training) sold 329 shares at $10.66 per share price. According to the SEC, on May 26, 2016, John Vincent Hamilton (VP, Regulatory & Clinical) sold 329 shares at $10.66 per share price.
Rewalk Robotics Ltd is an Israel-based medical device company. The Company is engaged in designing developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company has developed and is continuing to commercialize ReWalk an exoskeleton that uses its patented tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement. The Company offers two ReWalk products: ReWalk Personal and ReWalk Rehabilitation. ReWalk is a product that can fundamentally change the health and life experiences of users. ReWalk controls movement using subtle changes in the users center of gravity.